are bpc-157 and tb-500 approved by fda + Combination: Benefits, Differences, When to Use Both – Revolution Health & Wellness FDA panel backs compounded BPC-157,

A 30G needle is extremely thin (only 0.3mm in diameter), which minimizes pain as it penetrates the skin

As the dominant G-actin sequestering protein in mammalian cells, TB-500 binds globular actin with high affinity (Kd ~0.5 M) through a sophisticated triple-contact mechanism involving Lys-3, Lys-18, and Lys-38 residues, preventing spontaneous actin polymerization while maintaining a readily mobilizable reservoir for rapid cytoskeletal reorganization

Safe Uses in

[5] BPC-157 is stable at room temperature and bioavailable in rodent models when administered IM or IV

(2022, January 1)

Safety Profile, Side Effects, and Contraindications MOTS-c has a favorable safety profile in the published research to date, which is unsurprising given that it is an endogenous peptide that naturally circulates in human blood